Citigroup
FEED

Citigroup’s ENVUE MEDICAL INC NEW FEED Stock Holding History

Citigroup’s Portfolio FEED Stock Details FEED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Hold
0
– -$2 – 6231
2025
Q4 		– Hold
0
– – – 5931
2025
Q3 		– Sell
-21
Closed -$1.9K – 5973
2025
Q2 		$2.32K Buy
+21
New +$7.51K ﹤0.01% 5354
2022
Q2 		– Hold
0
– -$7K – 6506
2022
Q1 		– Hold
0
– – – 5692

Other funds holding FEED

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
PCM
Poehling Capital Management Madison, Wisconsin $466M AUM 24.17% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Citigroup's FEED Position: Q1 2026 in Review

Citigroup held its ENVUE MEDICAL INC NEW (FEED) position steady in Q1 2026 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #6231.

Citigroup first reported a position in FEED in Q2 2025 and has held it in 1 quarter since. The position peaked at $2.32K in Q2 2025. 13 funds tracked by Wall St. Rank hold FEED as of Q1 2026.

  • Citigroup held 0 shares of ENVUE MEDICAL INC NEW worth $0 as of Q1 2026.
  • Citigroup left its ENVUE MEDICAL INC NEW share count unchanged in Q1 2026.
  • ENVUE MEDICAL INC NEW made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #6231 holding.
  • Citigroup first reported a position in ENVUE MEDICAL INC NEW in Q2 2025 and has held it in 1 quarter since.
  • Citigroup's ENVUE MEDICAL INC NEW position peaked at $2.32K in Q2 2025.
  • 13 funds tracked by Wall St. Rank held ENVUE MEDICAL INC NEW as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.